Accord will build £50m manufacturing plant in UK

Generic drugmaker Accord Healthcare has announced a £50 million ($65 million) investment in the UK that will include the construction of a new medicines manufacturing facility.

NICE backs first 'take at home' prostate cancer pill

Thousands of men in the UK with advanced hormone-sensitive prostate cancer could soon be eligible for an oral therapy – Accord Healthcare's Orgovyx – that can be taken at home rather than r

How pharma can help the post-COVID recovery of European canc...

The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes physicians i

UK hospitals test Trump's theory that hydroxychloroquine war...

The world’s largest trial into hydroxychloroquine as a preventive treatment for COVID-19 is beginning in the UK. 

Boehringer bags CHMP backing for Ofev in rare lung disease